A growing body of literature points to how sufficient nutrition during the First 1,000 Days, from conception to the child’s second birthday, is essential for proper brain development, healthy growth and immune system that impacts the entirety of the child’s life and beyond(Reference Wrottesley, Lamper and Pisa1–5). In 2019, 144 million children under five were stunted, including 29·1 % of children in Africa and 21·8 % of children in Asia, which is indicative of chronic undernutrition within the first 1,000 days of life(5). Stunting is associated with cognitive impairment, reduced potential in school and increased risk of chronic disease later in life(Reference Hoddinott, Behrman and Alderman6–Reference Victora, Adair and Fall10). Additionally, malnutrition is intergenerational, as daughters of malnourished mothers are more likely to have low birth weight (LBW) children(Reference Delisle11,12) .
The 2008 Maternal and Child Undernutrition Lancet series advanced the idea that childhood stunting was the best measure of malnutrition and its long-term costs to society(Reference Victora, Adair and Fall10). Coined during a meeting with several development groups hosted by the World Bank in April 2010, the ‘First 1,000 Days’ mobilised the findings of the 2008 Lancet series to build momentum and advocacy in international development and global health(Reference Thurow7). The subsequent 2013 Lancet Series on Maternal and Child Nutrition further demonstrated early undernutrition as a serious hidden cause of child mortality(Reference Black, Victora and Walker3), increased risk of adult chronic diseases(Reference Bhutta13) and described building momentum with Scaling Up Nutrition programmes(Reference Nabarro14). The Scaling Up Nutrition movement represents a commitment by sixty-one low- and middle-income countries and four Indian States (as of 2020) to meet the Sustainable Development Goal Two of eliminating global hunger by 2030 by reducing stunting through focusing on the First 1,000 Days window(15–17).
However, with a focus on child health benefits, maternal nutritional status in terms of underlying malnutrition and women’s health outcomes lack explicit focus, such as maternal mortality, morbidities and well-being indicators. Though First 1,000 Days nutrition-specific and nutrition-sensitive interventions are largely facilitated through pregnant and lactating mothers, women’s health indicators may not be tracked and measured, which we argue represents a missed opportunity for developing interventions that are purposefully designed to improve both maternal and child health.
Maternal nutritional status and health outcomes
Maternal malnutrition is widely prevalent globally. A systematic review found that average intakes of protein, fat and total energy intakes were lower among pregnant women in low- and middle-income countries than in high-income countries and were frequently insufficient in a number of micronutrients, for example, folate, Fe, Ca and Zn(Reference Lee, Talegawkar and Merialdi18). Two linked reviews also revealed consistently suboptimal intakes of folate, Fe, vitamin D, fibre and energy among pregnant mothers in high-income countries(Reference Blumfield, Hure and Macdonald-Wicks19,Reference Blumfield, Hure and MacDonald-Wicks20) . Maternal undernutrition contributes to adverse effects in both mothers and infants including increased caesarean delivery rates and risk of maternal mortality in mothers and intra-uterine growth restriction in infants, which subsequently increases the risk for birth asphyxia and neonatal infections(Reference Black, Allen and Bhutta8,Reference Mason, Shrimpton and Saldanha21) . Low maternal BMI and anaemia are also associated with lethargy, reduced physical activity, diminished work capacity and increased risk for maternal mortality(Reference Mason, Shrimpton and Saldanha21).
Simultaneously, obesity is also prevalent in low- and middle-income countries and high-income countries, particularly among economically poor populations(Reference Perez-Escamilla, Bermudez and Buccini22–Reference Devlieger, Benhalima and Damm25). Maternal obesity is associated with serious adverse pregnancy outcomes including early pregnancy loss, preterm birth, stillbirth, gestational diabetes, pre-eclampsia and other hypertensive disorders, higher rates of labour induction and caesarean delivery, as well as associated with childhood obesity(Reference Siddiqui, Azria and Howell26–Reference Heslehurst, Vieira and Akhter31).
Maternal nutritional interventions
Nutrition-specific interventions and programmes include micronutrient supplementation and fortification, optimal exclusive breast-feeding and complementary feeding practices, and disease prevention and management to directly impact maternal, infant and child health outcomes(Reference Christian, Mullany and Hurley32). While the primary objective of the First 1,000 Days approach to nutrition is to reduce rates of stunting among children, mothers play an important role in facilitating interventions through strengthening her nutritional status during pregnancy and lactation. For example, a systematic review of thirty-two observational studies highlighted the potential of preconceptional and first trimester vitamin and mineral supplementation to reduce the risk of neural tube defects, LBW and preterm deliveries(Reference Ramakrishnan, Grant and Goldenberg33), while a number of maternal multiple micronutrient (MMN) supplementation trials found significant reductions in LBW(Reference Christian, Mullany and Hurley32,Reference van Lettow, Tweya and Rosenberg34,Reference Fawzi, Msamanga and Urassa35) .
Nutrition-sensitive interventions also highlight the importance of underlying factors that indirectly impact maternal and child nutrition, such as women’s empowerment(Reference Christian, Mullany and Hurley32,Reference Santoso, Kerr and Hoddinott36,Reference Ruel and Alderman37) . Women’s empowerment, the process of increasing agency and the status of women, influences household access to resources including allocation for child’s health and nutrition(Reference Santoso, Kerr and Hoddinott36). Four systematic reviews in the past 4 years evaluated the association between women’s empowerment and child nutrition. They showed promise for improving child health outcomes but described methodological challenges in various definitions of empowerment(Reference Santoso, Kerr and Hoddinott36,Reference Carlson, Kordas and Murray-Kolb38–Reference Pratley40) . While the value of women’s empowerment is acknowledged intrinsically to be beneficial to women and as a means to improve household nutrition, the reviews focused on the latter.
A gap in measuring women’s health and nutritional status
Though the interventions were facilitated through maternal nutrition, the measurement of women’s health outcomes was overlooked. For example, a large MMN supplementation trial in Tanzania conducted with 8468 HIV-negative pregnant women focused on child health outcomes, with LBW, prematurity and fetal death as the primary outcomes measured(Reference Fawzi, Msamanga and Urassa35). The trial, which found that supplementation significantly reduced the risk of LBW potentially due to lower risk of maternal anaemia, also followed a subset of children up to 11–14 years old. Follow-up on women’s health outcomes was not reported, even as potential confounders for child development outcomes(Reference Sudfeld, Manji and Darling41). More recently, the ‘Women First’ Trial with 7387 women in Guatemala, India, Pakistan and the Democratic Republic of the Congo found that periconceptual maternal MMN supplementation improved fetal growth-related birth outcomes(Reference Hambidge, Westcott and Garcés42). However, a recent Editorial noted the lack of maternal indicators measured in this trial including measures of maternal nutritional status, maternal morbidities, mental health and overall well-being(Reference Bhutta43). A 2017 Cochrane review of MMN supplementation for women during pregnancy included sixteen trials that reported effects on preterm births and LBW and fifteen trials that reported small-for-gestational age but only five trials reported maternal anaemia, four trials reporting caesarean section rates, three that reported maternal mortality rates and one trial that reported pre-eclampsia(Reference Haider and Bhutta44). Other maternal health outcomes (placental abruption, premature rupture of membranes, maternal well-being or satisfaction) were not reported by any of the trials. This represents a measurement gap in the evidence base particularly in health outcomes for women.
Nutritional interventions focused on the First 1,000 Days have not had the magnitude of effects on reducing childhood stunting as expected. Even with increases in the global rates of exclusive breast-feeding in the first 6 months to 44 % in 2019, rates of stunting remain persistently high at approximately 1 in 5 children (21·3 %)(5). In a specific example from rural Gambia, four decades of intensive health and nutritional interventions helped to halve childhood undernutrition rates but stunting remained persistently high at 30 %(Reference Nabwera, Fulford and Moore45). Some have suggested that highly publicised maternal and child initiatives, such as ‘safe motherhood’ and ‘child survival’, may not have had the expected impact because too little attention has been given to the nutritional status of women, including mothers(Reference Tinker, Daly and Green46) and the challenges they face in access to quality nutrition and care throughout their lives(Reference Mora and Nestel47). Mora and Nestel highlight the need for biologically meaningful indicators to screen undernutrition in women beyond Hb for anaemia, BMI and mid-upper arm circumference, which are inadequate for understanding micronutrient deficiencies(Reference Mora and Nestel47). In addition, attention to monitoring health outcomes in women is also lacking; for example, the follow-up for the maternal micronutrient study in Tanzania(Reference Sudfeld, Manji and Darling41) and the Women First trial that overlooked measuring outcomes in women(Reference Hambidge, Westcott and Garcés42,Reference Bhutta43) .
The vicious cycle of the research-advocacy gap
While the importance of maternal nutrition for the mothers may be implicitly understood in interventions within the First 1,000 Days approach, the missing explicit focus has led to a lack of evidence-based data. Christian and colleagues highlight in their review that the role of poor nutritional status during pregnancy and risk of maternal mortality are ‘unrecognized and underappreciated’ due to lack of funding and sufficient data to explore the association(Reference Christian, Mullany and Hurley32). The research-advocacy gap is a vicious cycle where limited knowledge leads to lower prioritisation, which equates to less research on the topic.
Many of these themes are similar to the issues raised by the Safe Motherhood Initiative pioneers in the late 1980s and early 1990s. Launched in 1987, Safe Motherhood Initiative was developed to counter the relative neglect of women’s health within the attention on child survival and the failure to address maternal health as intrinsically valuable, beyond its impact on child health(Reference AbouZahr48,Reference Thaddeus and Maine49) . Described as a ‘measurement trap’, limited data mutually reinforced low priority of maternal health(Reference Graham and Campbell50). Quality maternal health data are required to establish levels and trends, to identify determinants of risk and for evaluating the effectiveness of maternal health programming(Reference Graham and Campbell50). Consequently, a lack of quality maternal health data is both a result and contributor to the neglect of maternal health as a priority topic. Taken in the context of maternal and child nutrition, the relative gap in knowledge on the impact of maternal dietary interventions on the women themselves makes the topic hard to discuss and advocate for, which then contributes to lower prioritisation and less research. To help fill the current research-advocacy gap, there is a need for research on the impact of maternal nutrition on women’s health and understanding the gendered contexts of food and nutrition security. It is a missed opportunity that maternal mortality and morbidity outcomes, as well as maternal satisfaction, are not routinely measured in nutritional studies within the First 1,000 Days, such as in maternal MMN supplementation trials.
Conclusion
While the First 1,000 Days approach explores an intergenerational cycle of poverty and malnutrition through impacts on infants, there is also a need to understand the processes of entrenching poverty and malnutrition between inadequacies in maternal diet, adverse health outcomes for women and contextual factors, with the mothers at the centre. While mothers are targeted to facilitate nutritional interventions to improve infant health outcomes, the measurement of health outcomes in women is lacking. There is a great hope and potential for nutrition to strengthen infant growth and the society they will live in, but our vast dreams for the future cannot neglect the potential for benefits for women and her own life in the here and now.
Acknowledgements
Acknowledgements: This manuscript is part of the PRECISE (PREgnancy Care Integrating translational Science, Everywhere) Network. The authors would like to express their gratitude to the PRECISE Team for their support. In particular, we would especially like to thank PRECISE co-Principal Investigators, Professor Peter von Dadelszen and Professor Laura Magee, and Programme Managers, Marianne Vidler, Rachel Craik and Meriel Flint-O’Kane. Financial support: This publication received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. M.W.K. is supported by the Vanier Canada Graduate Scholarship funded by the Government of Canada through the Canadian Institutes of Health Research. Conflict of interest: The authors declare that they have no competing interests. Authorship: M.W.K. conceptualised the research, completed the literature review and drafted the initial draft. S.E.M. and R.E. supervised the process, contributed to interpreting the data, gave advice on the structure of the paper and critically reviewed all versions. All authors read and approved the final manuscript. Ethics of human subject participation: Not applicable.